P16 (gene)

Jump to: navigation, search


Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)
250px
PDB rendering based on 1a5e.
Identifiers
Symbols CDKN2A ; ARF; CDK4I; CDKN2; CMM2; INK4; INK4a; MLM; MTS1; TP16; p14; p14ARF; p16; p16INK4; p16INK4a; p19
External IDs OMIM: 600160 HomoloGene55430
RNA expression pattern
File:PBB GE CDKN2A 207039 at.png
File:PBB GE CDKN2A 209644 x at.png
File:PBB GE CDKN2A 211156 at.png
More reference expression data
Orthologs

| | bgcolor="#C3FDB8" | Human | bgcolor="#C3FDB8" | Mouse |-

    | bgcolor="#C3FDB8" | Entrez 
    | bgcolor="#eeeeee" style="border-top:2px solid #dddddd; border-right:2px solid #dddddd"| 1029
    | bgcolor="#eeeeee" style="border-top:2px solid #dddddd; border-right:2px solid #dddddd"| na

|-

     | bgcolor="#C3FDB8" | Ensembl
     | bgcolor="#eeeeee" style="border-top:2px solid #dddddd; border-right:2px solid #dddddd"| ENSG00000147889
     | bgcolor="#eeeeee" style="border-top:2px solid #dddddd; border-right:2px solid #dddddd"| na

|-

    | bgcolor="#C3FDB8" | Uniprot
    | bgcolor="#eeeeee" style="border-top:2px solid #dddddd; border-right:2px solid #dddddd"| P42771
    | bgcolor="#eeeeee" style="border-top:2px solid #dddddd; border-right:2px solid #dddddd"| na

|-

    | bgcolor="#C3FDB8" | Refseq
    | bgcolor="#eeeeee" style="border-top:2px solid #dddddd; border-right:2px solid #dddddd" | NM_000077 (mRNA)
NP_000068 (protein)
| bgcolor="#eeeeee" style="border-top:2px solid #dddddd; border-right:2px solid #dddddd" |na (mRNA)
na (protein)

|-

    | bgcolor="#C3FDB8" | Location
    | bgcolor="#eeeeee" style="border-top:2px solid #dddddd; border-right:2px solid #dddddd"|  Chr 9: 21.96 - 21.98 Mb 
    | bgcolor="#eeeeee" style="border-top:2px solid #dddddd; border-right:2px solid #dddddd"| na

|-

|-

    | bgcolor="#C3FDB8" | Pubmed search 
    | bgcolor="#eeeeee" style="border-top:2px solid #dddddd; border-right:2px solid #dddddd"| [1]
| bgcolor="#eeeeee" style="border-top:2px solid #dddddd; border-right:2px solid #dddddd"| na
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

WikiDoc Resources for P16 (gene)

Articles

Most recent articles on P16 (gene)

Most cited articles on P16 (gene)

Review articles on P16 (gene)

Articles on P16 (gene) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on P16 (gene)

Images of P16 (gene)

Photos of P16 (gene)

Podcasts & MP3s on P16 (gene)

Videos on P16 (gene)

Evidence Based Medicine

Cochrane Collaboration on P16 (gene)

Bandolier on P16 (gene)

TRIP on P16 (gene)

Clinical Trials

Ongoing Trials on P16 (gene) at Clinical Trials.gov

Trial results on P16 (gene)

Clinical Trials on P16 (gene) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on P16 (gene)

NICE Guidance on P16 (gene)

NHS PRODIGY Guidance

FDA on P16 (gene)

CDC on P16 (gene)

Books

Books on P16 (gene)

News

P16 (gene) in the news

Be alerted to news on P16 (gene)

News trends on P16 (gene)

Commentary

Blogs on P16 (gene)

Definitions

Definitions of P16 (gene)

Patient Resources / Community

Patient resources on P16 (gene)

Discussion groups on P16 (gene)

Patient Handouts on P16 (gene)

Directions to Hospitals Treating P16 (gene)

Risk calculators and risk factors for P16 (gene)

Healthcare Provider Resources

Symptoms of P16 (gene)

Causes & Risk Factors for P16 (gene)

Diagnostic studies for P16 (gene)

Treatment of P16 (gene)

Continuing Medical Education (CME)

CME Programs on P16 (gene)

International

P16 (gene) en Espanol

P16 (gene) en Francais

Business

P16 (gene) in the Marketplace

Patents on P16 (gene)

Experimental / Informatics

List of terms related to P16 (gene)


Overview

Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), also known as CDKN2A, is a human gene. This gene generates several transcript variants which differ in their first exons. At least three alternatively-spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, MDM2, a protein responsible for the degradation of p53 [1]. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene.[2]


p16 is a tumour suppressor gene. Mutations in p16 increase the risk of developing a variety of cancers, notably melanoma. p16 is an important gene in regulating the cell cycle.

Recent research on the p16 gene, published in Nature in September 2006, indicates that its increased expression as organisms age reduces the proliferation of stem cells. This reduction in the division and production of stem cells protects against cancer while increasing the risks associated with cellular senescence.

The p16 gene has an alternative reading frame (ARF) that encodes the p14 ARF protein. this is involved in stabilising P53 and is positively regulated by E2F.

p16INK4a is a major product of the CDKN2A locus. Its alternate reading frame product is p14ARF. p16INK4a regulates the cell cycle by binding and deactivating various cyclin-CDKcomplexes. A study published in 2007 in the New England Journal of medicine established that there is a strong association between polymorphisms on chromosome 9p21.3 (SNP, rs1333049) and coronary artery disease. This region codes for the INK4 proteins p16INK4a and p15INK4b. The corresponding genes are CDKN2A and CDKN2B. The proteins may inhibit cell growth induced by Transforming Growth Factor-beta.


References

  1. "Molecular biology of cancer", Oxford University Press, 2005, ISBN 978-0-19-926472-8, Section 5.3
  2. "Entrez Gene: CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)".

Further reading

  • Smith-Sørensen B, Hovig E (1996). "CDKN2A (p16INK4A) somatic and germline mutations". Hum. Mutat. 7 (4): 294–303. doi:10.1002/(SICI)1098-1004(1996)7:4<294::AID-HUMU2>3.0.CO;2-9. PMID 8723678.
  • Dracopoli NC, Fountain JW (1996). "CDKN2 mutations in melanoma". Cancer Surv. 26: 115–32. PMID 8783570.
  • Akita H (2003). "[Prognostic importance of altered expression of cell cycle regulators in lung cancer]". Nippon Rinsho. 60 Suppl 5: 267–71. PMID 12101670.
  • Kusy S, Larsen CJ, Roche J (2005). "p14ARF, p15INK4b and p16INK4a methylation status in chronic myelogenous leukemia". Leuk. Lymphoma. 45 (10): 1989–94. doi:10.1080/10428190410001714025. PMID 15370242.
  • Gjerset RA (2007). "DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer". J. Mol. Histol. 37 (5–7): 239–51. doi:10.1007/s10735-006-9040-y. PMID 16855788.
  • Yildiz IZ, Usubütün A, Firat P; et al. (2007). "Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature". Pathol. Res. Pract. 203 (6): 445–9. doi:10.1016/j.prp.2007.03.010. PMID 17543474.

External links



Linked-in.jpg